News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
601,746 Results
Type
Article (47651)
Company Profile (205)
Press Release (553890)
Multimedia
Podcasts (74)
Webinars (16)
Section
Business (166533)
Career Advice (2587)
Deals (30179)
Drug Delivery (108)
Drug Development (76338)
Employer Resources (155)
FDA (14043)
Job Trends (13321)
News (292667)
Policy (28377)
Tag
Academia (2630)
Academic (1)
Accelerated approval (7)
Adcomms (31)
Allergies (95)
Alliances (42978)
ALS (110)
Alzheimer's disease (1471)
Antibody-drug conjugate (ADC) (174)
Approvals (14016)
Artificial intelligence (308)
Autoimmune disease (33)
Automation (18)
Bankruptcy (327)
Best Places to Work (10510)
BIOSECURE Act (21)
Biosimilars (103)
Biotechnology (166)
Bladder cancer (91)
Brain cancer (34)
Breast cancer (346)
Cancer (2779)
Cardiovascular disease (220)
Career advice (2168)
Career pathing (33)
CAR-T (188)
CDC (30)
Cell therapy (505)
Cervical cancer (20)
Clinical research (62740)
Collaboration (972)
Company closure (3)
Compensation (437)
Complete response letters (24)
COVID-19 (2599)
CRISPR (60)
C-suite (318)
Cystic fibrosis (102)
Data (2840)
Decentralized trials (2)
Denatured (14)
Depression (65)
Diabetes (337)
Diagnostics (5976)
Digital health (18)
Diversity (5)
Diversity, equity & inclusion (42)
Drug discovery (134)
Drug pricing (122)
Drug shortages (25)
Duchenne muscular dystrophy (121)
Earnings (60271)
Editorial (43)
Employer branding (20)
Employer resources (141)
Events (88720)
Executive appointments (867)
FDA (15531)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (875)
Gene editing (131)
Generative AI (22)
Gene therapy (395)
GLP-1 (795)
Government (4298)
Grass and pollen (5)
Guidances (177)
Healthcare (16581)
Huntington's disease (32)
IgA nephropathy (42)
Immunology and inflammation (163)
Immuno-oncology (9)
Indications (37)
Infectious disease (2769)
Inflammatory bowel disease (149)
Inflation Reduction Act (13)
Influenza (62)
Intellectual property (112)
Interviews (531)
IPO (13730)
IRA (51)
Job creations (3184)
Job search strategy (1786)
Kidney cancer (15)
Labor market (42)
Layoffs (494)
Leadership (25)
Legal (6173)
Liver cancer (80)
Lung cancer (403)
Lymphoma (198)
Machine learning (9)
Management (54)
Manufacturing (356)
MASH (93)
Medical device (10826)
Medtech (10830)
Mergers & acquisitions (17095)
Metabolic disorders (844)
Multiple sclerosis (97)
NASH (23)
Neurodegenerative disease (128)
Neuropsychiatric disorders (37)
Neuroscience (2157)
NextGen: Class of 2025 (5859)
Non-profit (4093)
Now hiring (41)
Obesity (421)
Opinion (263)
Ovarian cancer (96)
Pain (111)
Pancreatic cancer (115)
Parkinson's disease (186)
Partnered (21)
Patents (284)
Patient recruitment (147)
Peanut (48)
People (54895)
Pharmaceutical (34)
Pharmacy benefit managers (13)
Phase I (19604)
Phase II (27663)
Phase III (20765)
Pipeline (1560)
Policy (207)
Postmarket research (2364)
Preclinical (8150)
Press Release (69)
Prostate cancer (131)
Psychedelics (41)
Radiopharmaceuticals (242)
Rare diseases (467)
Real estate (5083)
Recruiting (66)
Regulatory (20250)
Reports (34)
Research institute (2249)
Resumes & cover letters (384)
Rett syndrome (9)
RNA editing (8)
RSV (47)
Schizophrenia (89)
Series A (152)
Series B (100)
Service/supplier (11)
Sickle cell disease (62)
Special edition (18)
Spinal muscular atrophy (150)
Sponsored (31)
Startups (3340)
State (2)
Stomach cancer (15)
Supply chain (67)
Tariffs (52)
The Weekly (59)
Vaccines (774)
Venture capital (52)
Weight loss (269)
Women's health (34)
Worklife (19)
Date
Last 7 days (593)
Last 30 days (2130)
Last 365 days (29335)
2025 (15090)
2024 (32904)
2023 (36620)
2022 (47328)
2021 (50862)
2020 (48782)
2019 (41692)
2018 (31699)
2017 (29258)
2016 (27960)
2015 (32469)
2014 (26453)
2013 (22586)
2012 (21904)
2011 (22792)
2010 (20386)
Location
Africa (818)
Alabama (60)
Alaska (5)
Arizona (174)
Arkansas (11)
Asia (37295)
Australia (7482)
California (6646)
Canada (2144)
China (651)
Colorado (270)
Connecticut (275)
Delaware (182)
Europe (83687)
Florida (1019)
Georgia (207)
Hawaii (1)
Idaho (54)
Illinois (585)
India (27)
Indiana (333)
Iowa (14)
Japan (214)
Kansas (102)
Kentucky (24)
Louisiana (13)
Maine (50)
Maryland (934)
Massachusetts (4823)
Michigan (224)
Minnesota (383)
Mississippi (2)
Missouri (80)
Montana (25)
Nebraska (24)
Nevada (74)
New Hampshire (67)
New Jersey (1882)
New Mexico (25)
New York (1886)
North Carolina (996)
North Dakota (8)
Northern California (2908)
Ohio (202)
Oklahoma (12)
Oregon (30)
Pennsylvania (1391)
Puerto Rico (17)
Rhode Island (33)
South America (1110)
South Carolina (30)
South Dakota (1)
Southern California (2512)
Tennessee (107)
Texas (1012)
United States (24539)
Utah (206)
Virginia (169)
Washington D.C. (65)
Washington State (603)
West Virginia (4)
Wisconsin (56)
601,746 Results for "fortress biotech formerly known as coronado biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics
June 2, 2025
·
6 min read
Press Releases
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
May 15, 2025
·
14 min read
Press Releases
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
April 1, 2025
·
18 min read
Press Releases
Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference
May 8, 2025
·
1 min read
Press Releases
Partex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform
March 18, 2025
·
6 min read
Business
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty revenue, today announced financial results and recent corporate highlights for the first quarter ended March 31, 2024.
May 15, 2024
·
15 min read
Business
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty revenue, today announced financial results and recent corporate highlights for the full-year ended December 31, 2023.
March 28, 2024
·
14 min read
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
Fortress Biotech, Inc. today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company.
May 16, 2024
·
1 min read
Press Releases
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease
January 6, 2025
·
10 min read
Press Releases
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
November 15, 2024
·
15 min read
1 of 60,175
Next
